Assetmark, Inc Abb Vie Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Assetmark, Inc holds 150,509 shares of ABBV stock, worth $27.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

150,509

Previous 138,616 8.58%

Holding current value

$27.1 Million

Previous $23.8 Million 25.01%

% of portfolio

0.09%

Previous 0.07%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$163.84 - $199.33 $1.95 Million - $2.37 Million	11,893 Added 8.58%	150,509 $29.7 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $759,399 - $886,808	4,906 Added 3.67%	138,616 $23.8 Million
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $521,492 - $594,192	3,263 Added 2.5%	133,710 $24.3 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $915,865 - $1.03 Million	6,656 Added 5.38%	130,447 $20.2 Million
Q3 2023 Oct 27, 2023	BUY	$133.59 - $154.65 $193,304 - $223,778	1,447 Added 1.18%	123,791 $18.5 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $198,499 - $247,020	1,498 Added 1.24%	122,344 $16.5 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $905,547 - $1.04 Million	6,262 Added 5.46%	120,846 $19.3 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $1.67 Million - $2 Million	12,083 Added 11.79%	114,584 $18.5 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $793,315 - $909,880	5,911 Added 6.12%	102,501 $13.8 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $668,833 - $850,305	4,860 Added 5.3%	96,590 $14.8 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $2.87 Million - $3.57 Million	-21,776 Reduced 19.18%	91,730 $14.9 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $17,511 - $22,156	-163 Reduced 0.14%	113,506 $15.4 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $209,076 - $237,332	1,965 Added 1.76%	113,669 $12.3 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $6.08 Million - $6.78 Million	-57,803 Reduced 34.1%	111,704 $12.6 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $39,897 - $43,921	-390 Reduced 0.23%	169,507 $18.3 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $5.49 Million - $7.41 Million	-68,192 Reduced 28.64%	169,897 $18.2 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $7.81 Million - $9.17 Million	90,918 Added 61.78%	238,089 $20.9 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $707,213 - $946,357	-9,639 Reduced 6.15%	147,171 $14 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $162,088 - $245,746	-2,513 Reduced 1.58%	156,810 $11.9 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $6.24 Million - $7.81 Million	86,524 Added 118.85%	159,323 $14.1 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $1.64 Million - $1.97 Million	26,027 Added 55.65%	72,799 $5.51 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $613,835 - $784,625	9,343 Added 24.96%	46,772 $3.4 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $213,677 - $251,488	2,770 Added 7.99%	37,429 $3.02 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $14.3 Million - $17.6 Million	-183,754 Reduced 84.13%	34,659 $3.2 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $1.55 Million - $1.73 Million	17,483 Added 8.7%	218,413 $20.7 Million
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $2 Million - $2.37 Million	22,288 Added 12.48%	200,930 $18.6 Million
Q1 2018 May 16, 2018	BUY	$92.01 - $123.21 $5.86 Million - $7.85 Million	63,704 Added 55.42%	178,642 $16.9 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $2.3 Million - $2.52 Million	-25,654 Reduced 18.25%	114,938 $11.1 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $5.62 Million - $7.18 Million	80,496 Added 133.95%	140,592 $12.5 Million
Q2 2017 Aug 15, 2017	BUY	N/A	14,200 Added 30.94%	60,096 $4.36 Million
Q1 2017 Sep 15, 2017	BUY	N/A	13,304 Added 40.82%	45,896 $2.99 Million
Q4 2016 Sep 15, 2017	SELL	N/A	-183 Reduced 0.56%	32,592 $2.04 Million
Q3 2016 Sep 15, 2017	SELL	N/A	-6,713 Reduced 17.0%	32,775 $2.07 Million
Q2 2016 Sep 15, 2017	BUY	N/A	1,344 Added 3.52%	39,488 $2.45 Million
Q1 2016 Sep 15, 2017	BUY	N/A	14,231 Added 59.51%	38,144 $2.18 Million
Q4 2015 Sep 15, 2017	BUY	N/A	23,913	23,913 $1.42 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account